- Home
- ABSI vs REFI Comparison
ABSI vs REFI Comparison
Compare ABSI & REFI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABSI
- REFI
- Stock Information
- Founded
- ABSI 2011
- REFI 2021
- Country
- ABSI United States
- REFI United States
- Employees
- ABSI N/A
- REFI N/A
- Industry
- ABSI Biotechnology: Pharmaceutical Preparations
- REFI Real Estate Investment Trusts
- Sector
- ABSI Health Care
- REFI Real Estate
- Exchange
- ABSI Nasdaq
- REFI Nasdaq
- Market Cap
- ABSI 353.8M
- REFI 314.2M
- IPO Year
- ABSI 2021
- REFI 2021
- Fundamental
- Price
- ABSI $3.01
- REFI $15.39
- Analyst Decision
- ABSI Strong Buy
- REFI Strong Buy
- Analyst Count
- ABSI 6
- REFI 3
- Target Price
- ABSI $7.83
- REFI $20.00
- AVG Volume (30 Days)
- ABSI 4.4M
- REFI 193.1K
- Earning Date
- ABSI 03-18-2025
- REFI 03-12-2025
- Dividend Yield
- ABSI N/A
- REFI 13.32%
- EPS Growth
- ABSI N/A
- REFI N/A
- EPS
- ABSI N/A
- REFI 1.88
- Revenue
- ABSI $4,534,000.00
- REFI $55,534,183.00
- Revenue This Year
- ABSI $257.06
- REFI N/A
- Revenue Next Year
- ABSI $112.29
- REFI N/A
- P/E Ratio
- ABSI N/A
- REFI $8.23
- Revenue Growth
- ABSI N/A
- REFI N/A
- 52 Week Low
- ABSI $2.45
- REFI $14.82
- 52 Week High
- ABSI $6.72
- REFI $16.47
- Technical
- Relative Strength Index (RSI)
- ABSI 38.78
- REFI 39.44
- Support Level
- ABSI $2.81
- REFI $15.28
- Resistance Level
- ABSI $3.15
- REFI $15.67
- Average True Range (ATR)
- ABSI 0.23
- REFI 0.30
- MACD
- ABSI -0.02
- REFI -0.07
- Stochastic Oscillator
- ABSI 33.61
- REFI 26.05
About ABSI Absci Corporation
Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process.
About REFI Chicago Atlantic Real Estate Finance Inc.
Chicago Atlantic Real Estate Finance Inc is engaged in a commercial real estate finance company. Its primary investment objective is to provide attractive risk-adjusted returns for stockholders over time, through consistent current income dividends and other distributions and secondarily through capital appreciation.